Jyoti Bhagia, MD, is a Consultant in the Division of Child and Adolescent Psychiatry and Psychology in the Department of Psychiatry & Psychology at Mayo Clinic. She serves as the Director of the ADHD Clinic at Mayo, where she oversees the treatment of pediatric patients diagnosed with ADHD and related disorders. She has led quality projects for standardizing the assessment and treatment of ADHD and had received certificate of silver level quality fellow by Mayo Clinic. She is a member of several Mayo Clinic committees including, the Child and Adolescent Psychiatry Education Committee and the Multidisciplinary ADHD Workgroup. Her research is focused on areas including the response to stimulant medications in children with ADHD based on genotype and clinical correlation of ferritin with ADHD. She has published articles in Mayo Clinic Proceedings, Therapeutic Drug Monitoring and Global Pediatric Health. She has written a book chapter in Mayo Neurology Board Review. She has been a recipient for several Honors/Awards: Silver Quality fellow- ADHD project 2009; Leading Physician of the World - Top Psychiatrist - International Association of Healthcare Professionals, New York, New York 2012 – 2013; Mayo Clinic - Karolinska Institutet Travel Award - Department of Psychiatry, Mayo Clinic. ADHD medication and predictors of treatment outcome - a naturalistic study in 02/2014 and Mayo Clinic-Karolinska Institutet Travel Award- ADHD ADAPT Study in 02/2016. Jyoti Bhagia, MD, is a Consultant in the Division of Child and Adolescent Psychiatry and Psychology in the Department of Psychiatry & Psychology at Mayo Clinic. She serves as the Director of the ADHD Clinic at Mayo, where she oversees the treatment of pediatric patients diagnosed with ADHD and related disorders. She has led quality projects for standardizing the assessment and treatment of ADHD and had received certificate of silver level quality fellow by Mayo Clinic. She is a member of several Mayo Clinic committees including, the Child and Adolescent Psychiatry Education Committee and the Multidisciplinary ADHD Workgroup. Her research is focused on areas including the response to stimulant medications in children with ADHD based on genotype and clinical correlation of ferritin with ADHD. She has published articles in Mayo Clinic Proceedings, Therapeutic Drug Monitoring and Global Pediatric Health. She has written a book chapter in Mayo Neurology Board Review. She has been a recipient for several Honors/Awards: Silver Quality fellow- ADHD project 2009; Leading Physician of the World - Top Psychiatrist - International Association of Healthcare Professionals, New York, New York 2012 – 2013; Mayo Clinic - Karolinska Institutet Travel Award - Department of Psychiatry, Mayo Clinic. ADHD medication and predictors of treatment outcome - a naturalistic study in 02/2014 and Mayo Clinic-Karolinska Institutet Travel Award- ADHD ADAPT Study in 02/2016.

pediatric Psychiatry